Genetic diversity of HCV in Brazil

Antiviral Therapy

Volumn 18, Issue 3 PARTB, 2013, Pages 435-444

  Lampe, Elisabeth ^a   Lewis Ximenez, Lia ^a   Espírito Santo, Marcia P ^a   Delvaux, Nathália M ^a   Pereira, Sergio A ^a   Peres Da Silva, Allan ^a   Martins, Regina M B ^b   Soares, Marcelo A ^c   Santos, André F ^c   Vidal, Luãnna L ^c   Germano, Fabiana N ^c   De Martinez, Ana Maria B ^d   Basso, Rossana ^d   Rebello Pinho, João R ^e   Malta, Fernanda M ^e   Gomes Gouvêa, Michele ^e   Moliterno, Ricardo A ^f   Bertolini, Dennis A ^f   Fujishima, Mayara A T ^f   Bello, Gonzalo ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BRAZIL; CONTROLLED STUDY; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS C VIRUS; MONOPHYLY; NONHUMAN; NS5B GENE; PHYLOGENY; PRIORITY JOURNAL; REVIEW; VIRUS GENE; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE;

BASE SEQUENCE; BRAZIL; EPIDEMICS; GENETIC VARIATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, RNA; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84879615735     PISSN: 13596535     EISSN: 20402058     Source Type: Journal    
DOI: 10.3851/IMP2606     Document Type: Review

References (38)

1. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011; 17:107-115.
2. Simmonds P, Bukh J, Combet C, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005; 42:962-973.
3. Pickett BE, Striker R, Lefkowitz EJ. Evidence for separation of HCV subtype 1a into two distinct clades. J Viral Hepat 2011; 18:608-618.
4. Hauri AM, Armstrong GL, Hutin YJ. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS 2004; 15:7-16.
5. Tanaka Y, Hanada K, Orito E, et al. Molecular evolutionar analyses implicate injection treatment for schistosomiasis in the initial hepatitis C epidemics in Japan. J Hepatol 2005; 42:47-53.
6. Pybus OG, Cochrane A, Holmes EC, Simmonds P. The hepatitis C virus epidemic among injecting drug users. Infect Genet Evol 2005; 5:131-139.
7. Brazil Health Ministry. Department of STDs, AIDS and viral hepatitis, Brasil. [Viral hepatitis in numbers]. Portuguese. (Accessed 15 April 2013.) Available from http://www.aids.gov.br/pagina/hepatites-virais-em-numero
8. Zarife MA, Silva LK, Silva MB, et al. Prevalence of hepatiti C virus infection in north-eastern Brazil: a population-base study. Trans R Soc Trop Med Hyg 2006; 100:663-668.
9. Stuyver L, Rossau R, Wyseur A, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993; 74:1093-1102.
10. Holland PV, Barrera JM, Ercilla MG, et al. Genotyping hepatitis C virus isolates from Spain, Brazil, China, and Macau by a simplified PCR method. J Clin Microbiol 1996 34:2372-2378.
11. Martins RM, Vanderborght BO, Yoshida CF. Hepatitis C virus genotypes among blood donors from different region of Brazil. Mem Inst Oswaldo Cruz 1998; 93:299-300.
12. Oliveira ML, Bastos FI, Sabino RR, et al. Distribution of HCV genotypes among different exposure categories in Brazil. Braz J Med Biol Res 1999; 32:279-282.
13. Silva LK, Parana R, Souza SP, et al. Hepatitis C virus genotypes in a northeastern area of Brazil. Am J Trop Med Hyg 2000; 62:257-260.
14. Pereira LM, Spinelli V, Ximenes RA, et al. Chronic hepatiti C infection: influence of the viral load, genotypes, and GBV-C/HGV coinfection on the severity of the disease in a Brazilian population. J Med Virol 2002; 67:27-32.
15. Perez RM, Ferraz ML, Figueiredo MS, et al. Unexpected distribution of hepatitis C virus genotypes in patients on hemodialysis and kidney transplant recipients. J Med Virol 2003; 69:489-494.
16. Campiotto S, Pinho JR, Carrilho FJ, et al. Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res 2005; 38:41-49.
17. Martins RM, Teles SA, Freitas NR, et al. Distribution of hepatitis C virus genotypes among blood donors from midwest region of Brazil. Rev Inst Med Trop Sao Paulo 2006; 48:53-55.
18. Carneiro MA, Teles SA, Lampe E, et al. Molecular and epidemiological study on nosocomial transmission of HCV in hemodialysis patients in Brazil. J Med Virol 2007; 79:1325-1333.
19. Freitas SZ, da Cunha RV, Martins RM, Teles SA, Ibanhes ML, Motta-Castro AR. Prevalence, genotypes and risk factors associated with hepatitis C virus infection in hemodialysis patients in Campo Grande, MS, Brazil. Mem Inst Oswaldo Cruz 2008; 103:405-408.
20. Lopes CL, Teles SA, Espirito-Santo MP, et al. Prevalence, risk factors and genotypes of hepatitis C virus infection among drug users, central-western Brazil. Rev Saude Publica 2009; 43 Suppl 1:43-50.
21. Oliveira ML, Yoshida CF, Telles PR, et al. Trends in HCV prevalence, risk factors and distribution of viral genotypes in injecting drug users: findings from two cross-sectional studies. Epidemiol Infect 2009; 137:970-979.
22. Lampe E, Espirito-Santo MP, Martins RM, Bello G. Epidemic history of hepatitis C virus in Brazil. Infect Genet Evol 2010; 10:886-895.
23. Romano CM, de Carvalho-Mello IM, Jamal LF, et al. Social networks shape the transmission dynamics of hepatitis C virus. PLoS ONE 2010; 5:e11170.
24. Peres-da-Silva A, Almeida AJ, Lampe E. Genetic diversity of NS3 protease from Brazilian HCV isolates and possible implications for therapy with direct-acting antiviral drugs. Mem Inst Oswaldo Cruz 2012; 107:254-261.
25. Oliveira ML, Bastos FI, Telles PR, et al. Epidemiological and genetic analyses of hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil. J Clin Virol 2009; 44:200-206.
26. Vieira DS, Alvarado-Mora MV, Botelho L, Carrilho FJ, Pinho JR, Salcedo JM. Distribution of hepatitis C virus (HCV) genotypes in patients with chronic infection from Rondonia, Brazil. Virol J 2011; 8:165.
27. Ribeiro LC, Souto FJ, do Espírito-Santo MP, G-Oliveira R, Lampe E. An autochthonous case of hepatitis C virus genotype 5a in Brazil: phylogenetic analysis. Arch Virol 2009; 154:665-670.
28. Kuiken C, Yusim K, Boykin L, Richardson R. The Los Alamos hepatitis C sequence database. Bioinformatics 2005; 21:379-384.
29. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997; 25:4876-4882.
30. Guindon S, Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 2003; 52:696-704.
31. Guindon S, Lethiec F, Duroux P, Gascuel O. PHYML Online - a web server for fast maximum likelihood-based phylogenetic inference. Nucleic Acids Res 2005; 33:W557-W559.
32. Rodríguez F, Oliver JL, Marin A, Medina JR. The general stochastic model of nucleotide substitution. J Theor Biol 1990; 142:485-501.
33. Posada D. jModelTest: phylogenetic model averaging. Mol Biol Evol 2008; 25:1253-1256.
34. Anisimova M, Gascuel O. Approximate likelihood-ratio test for branches: a fast, accurate, and powerful alternative. Syst Biol 2006; 55:539-552.
35. Peres-da-Silva A, Almeida AJ, Lampe E. Genetic diversity of NS3 protease from Brazilian HCV isolates and possible implications for therapy with direct-acting antiviral drugs. Mem Inst Oswaldo Cruz 2012; 107:254-261.
36. Bae A, Sun SC, Qi X, et al. Susceptibility of treatmentnaive hepatitis C virus (HCV) clinical isolates to HCV protease inhibitors. Antimicrob Agents Chemother 2010; 54:5288-5297.
37. Halfon P, Locarnini S. Hepatitis C virus resistance to protease inhibitors. J Hepatol 2011; 55:192-206.
38. Lenz O, Fevery B, Vijgen J, et al. TMC435 in patients infected with HCV genotype 1 who have failed previous pegylated interferon/ribavirin treatment: virologic analyses of the ASPIRE trial. J Hepatol 2012; 56 Suppl 2:S5.